Your Location:
Home >
Browse articles >
Shaoyaotang Treats Ulcerative Colitis by Inhibiting HIF-1α and Regulating Th17/Treg Balance
Shaoyaotang Treats Ulcerative Colitis by Inhibiting HIF-1
α and Regulating Th17/Treg Balance- Chinese Journal of Experimental Traditional Medical Formulae Vol. 27, Issue 16, Pages: 9-15(2021)
DOI: 10.13422/j.cnki.syfjx.20211503
Scan QR Code
Full Text(HTML)
Figs( 4 ) Tabs( 5 )
References
Publication Info
Metrics
133
Views
97
Downloads
19
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Mechanism of Shaoyaotang in Ameliorating Colitis-associated Carcinogenesis in Mice via Modulating AMPK/NF-κB/HIF-1α Signaling Pathway
Shaoyaotang Regulates TLR4/MyD88/NF-κB Signaling Pathway to Protect Intestinal Mucosal Barrier in Ulcerative Colitis
Shaoyaotang Regulates miRNA-155-mediated SOCS1/JAK1/STAT1 Signaling Pathway to Affect Macrophage Polarization
Shaoyaotang Ameliorates Ulcerative Colitis by Regulating miR-155-5p
Effect and Mechanisms of Shaoyaotang on Murine Ulcerative Colitis via Modulating Macrophage Glycolytic Reprogramming and Polarization Through HIF-1α Pathway
Related Author
CHEN Xue
WANG Chenglei
WU Ying
YANG Bingwei
ZHAI Haoyu
LI Weidong
WU Dongsheng
ZHANG Yu
Related Institution
Shaanxi University of Chinese Medicine
Hospital of Chengdu University of Traditional Chinese Medicine
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Anhui University of Chinese Medicine
Liaoning Vocational College of Medicine


